Literature DB >> 1283560

Axonal flow blockade induces alpha-CGRP mRNA expression in rat motoneurons.

K Katoh1, M Tohyama, K Noguchi, E Senba.   

Abstract

Axonal flow of motoneurons was blocked in the sciatic nerve by the application of vinblastine at a low concentration (100 microM) not considered likely to cause axonal degeneration. The number of motoneurons expressing alpha-calcitonin gene-related peptide (CGRP) mRNA was significantly increased by vinblastine application, while the expression of beta-CGRP mRNA was not influenced. These findings suggest that the synthesis of these two peptides is differentially regulated and that alpha-CGRP mRNA is possibly down-regulated by unknown factor(s) which normally undergo retrograde transport from the periphery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283560     DOI: 10.1016/0006-8993(92)90864-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Brain-derived neurotrophic factor regulates expression of androgen receptors in perineal motoneurons.

Authors:  H A Al-Shamma; A P Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Exercise-induced gene expression changes in the rat spinal cord.

Authors:  Victoria M Perreau; Paul A Adlard; Aileen J Anderson; Carl W Cotman
Journal:  Gene Expr       Date:  2005

3.  Disruption of axoplasmic transport induces mechanical sensitivity in intact rat C-fibre nociceptor axons.

Authors:  Andrew Dilley; Geoffrey M Bove
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

4.  Time course of ongoing activity during neuritis and following axonal transport disruption.

Authors:  Ieva Satkeviciute; George Goodwin; Geoffrey M Bove; Andrew Dilley
Journal:  J Neurophysiol       Date:  2018-02-21       Impact factor: 2.714

5.  Neuritis and vinblastine-induced axonal transport disruption lead to signs of altered dorsal horn excitability.

Authors:  Ieva Satkeviciute; Andrew Dilley
Journal:  Mol Pain       Date:  2018-08-21       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.